Advertisement
Home Tags Diabetes: Type II

Tag: Diabetes: Type II

After induction short-term intensive insulin therapy (IIT)

Metformin After Induction Tx May Preserve Beta-Cell Function

Also associated with better glycemic control than repeat intensive insulin therapy after induction IIT
For obese adults with type 2 diabetes

Greater Weight Loss With RYGB in Obese With T2DM at Three Years

Lasting improvements in weight, HbA1c, cardiovascular risk vs. intensive weight management
Eating speed can affect changes in obesity

Eating Slower Tied to Lower Obesity Risk in Type 2 Diabetes

Slower eating also found to be associated with reduced BMI, waist circumference
Risk of developing type 2 diabetes is associated with subtle elevations of glucose and lipids more than 20 years before diagnosis

Diabetes Signs May Be Present 20 Years Before Diagnosis

Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes
A consultation model that facilitates person-centered diabetes care results in more patient involvement

Diabetes Consultation Model Helps Patient Involvement in Care

Majority of patients reported shared decision making; they felt more involved and it was widely appreciated
An interactive

Interactive Simulation Can Affect Activity Intentions in T2DM

Increased participant intentions to exercise with walking a week after completing intervention
For patients with type 2 diabetes

Increased Long-Term Mortality for All Weight Categories in T2DM

Nadir at BMI of 25 to <30 kg/m²; stepwise increase to peak for patients with BMI ≥40 kg/m²
A long-term intensive lifestyle intervention in overweight and obese adults with type 2 diabetes mellitus is associated with greater cerebral blood flow

Intensive Lifestyle Intervention Linked to Cerebral Blood Flow

In obese, overweight adults with T2DM, long-term weight loss intervention tied to greater blood flow
Compared to placebo

Pioglitazone Associated With Lower Blood Leptin in Diabetes

In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
For healthy adults and individuals with well-controlled type 2 diabetes

DPP-4 Inhibitor Has Dissociated Effects on β-Cell Function

Single dose of sitagliptin linked to increases in standardized insulin secretion, active GIP, GLP-1